Telix and Regeneron Partner to Advance Radiopharma Therapies
Melbourne, Australia & Tarrytown, New York | April 13, 2026 Telix Pharmaceuticals and Regeneron Pharmaceuticals have announced a strategic...
AI in Healthcare Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
Melbourne, Australia & Tarrytown, New York | April 13, 2026 Telix Pharmaceuticals and Regeneron Pharmaceuticals have announced a strategic...
Pasadena, CA – October 21, 2025 – Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) has officially completed its global licensing and...
Andelyn Biosciences, a leading cell and gene therapy CDMO, has partnered with Tern Therapeutics to perform late-stage Process Performance...
Veeva Systems (NYSE: VEEV) today announced a strategic collaboration with global biotechnology leader Amgen to drive innovation in clinical...
